Skip to content
Case report Open access

A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis.

Sep 2026 · Journal of UOEH · Vol 48 3, pp. 175-179 · 0 citations
Medicine

TL;DR

Clinicians should recognize that catatonia and NCSE may coexist and overlap in GABA-A-related pathophysiology, and that early GABA-A-targeted interventions, including m-ECT, may be critical for recovery.

Abstract

Catatonia is a psychomotor syndrome that occurs in various psychiatric, neurological, and medical conditions. Differentiating malignant catatonia from neuroleptic malignant syndrome (NMS) and non-convulsive status epilepticus (NCSE) is particularly challenging in complex cases involving multiple contributing factors. Both catatonia and NCSE have been associated with dysfunction of the gamma-aminobutyric acid (GABA)-A receptor system, which may underlie overlapping clinical features. We report the case of a 43-year-old man with a long-standing history of schizophrenia who developed malignant catatonia following a suicide attempt that resulted in multiple traumatic injuries. Postoperatively, he exhibited autonomic instability, decreased consciousness, muscle rigidity, and catatonic signs. An electroencephalogram revealed generalized spike-and-wave activity consistent with NCSE, and levetiracetam was initiated. Despite the resolution of the epileptiform discharges, the catatonic symptoms persisted. A transient positive response to lorazepam supported the diagnosis of malignant catatonia. Modified electroconvulsive therapy (m-ECT) was introduced on day 40 of hospitalization. After four sessions, the patient showed marked improvement in both motor and autonomic symptoms. Thirteen sessions were completed, and the patient was discharged on day 81. He remained relapse-free for over five years. This case highlights the importance of considering malignant catatonia in patients with schizophrenia who present with persistent catatonic symptoms despite adequate treatment of NCSE. Although antiepileptic therapy suppressed epileptiform activity, resolution of catatonia required m-ECT, suggesting that seizure control alone may be insufficient. Clinicians should recognize that catatonia and NCSE may coexist and overlap in GABA-A-related pathophysiology, and that early GABA-A-targeted interventions, including m-ECT, may be critical for recovery.

Read PDF

Similar papers

Case report Open access Aug 2026

Acute catatonia and psychosis in the context of seizure exacerbation in epilepsy: a case report

Background The co-occurrence of seizure-associated psychosis and catatonia in epilepsy is diagnostically challenging, particularly when complex pre-existing psychiatric comorbidities complicate attribution. Few reports describe this triad in the context of an antidepressant switch. Case presentation We report a 44-year...

Maryam Alowais, Zainab Khan, Fares Salamah et al. · 0 citations
Open access Sep 2026

Temporal association between adjunctive repetitive transcranial magnetic stimulation and seizure reduction in a pediatric patient with DNM1L-associated EMPF1: a case report

Encephalopathy, lethal, due to defective mitochondrial and peroxisomal fission 1 (EMPF1) is a rare, severe mitochondrial disorder characterized by acute-onset refractory seizures that rapidly progress to status epilepticus and are associated with a poor prognosis. Conventional therapies, including antiepileptic dru...

Xiang-Hui Chen, Ping-Lian Sun, Xiao-Hong Ren et al. · 0 citations
Sep 2026

Unusual Neurodevelopmental Triad: Developmental and Epileptic Encephalopathy With Spike-Wave Activation in Sleep, Narcolepsy Type 1, and Mosaic Turner Syndrome

Developmental and epileptic encephalopathy with spike wave activation in sleep (DEE-SWAS), narcolepsy type 1 (NT1), and Turner syndrome (TS) have been independently described in pediatric populations. However, their simultaneous occurrence has not been reported. We present, to our knowledge, the first documented ca...

Timothy Dixon, S. Ahmed, Ronald Perkin et al. · 0 citations
Sep 2026

Prolonged Post-Electroconvulsive Therapy Delirium in Treatment-Resistant Depression With Central Nervous System Risk Factors Under Programmed Cell Death Protein 1 Inhibitor Therapy: A Case Report.

We report a diagnostically challenging case of treatment-resistant depression (TRD) in a 52-year-old woman with multiple factors potentially increasing susceptibility to central nervous system (CNS) adverse effects, including global cortical atrophy, concomitant lithium and antipsychotic treatment, and ongoing programm...

E. Berthold, Meltem Baskonus, Joan Koti et al. · 0 citations
Case report Open access Aug 2026

Behavioral and autonomic manifestations of suspected focal impaired awareness seizures supported by interictal electroencephalographic findings in three dogs: a case series

All three dogs were treated with antiseizure medication, which resulted in a decrease in both the frequency and intensity of episodes, with complete seizure freedom achieved in two dogs.

Adriana Czerwik, Agnieszka Olszewska, Daniela Farke et al. · 0 citations
Case report Sep 2026

Non-convulsive status epilepticus revealing acute deterioration in AARS2 mutation–associated progressive leukoencephalopathy

This case identifies NCSE as a potential cause of clinical deterioration in AARS2-related leukoencephalopathy and highlights the importance of considering NCSE in patients presenting with subacute neurological deterioration.

Meryem Tuba Sönmez, Hikmet Saçmacı · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.